Brief: Elanco Announces FDA Approves Improved Zenrelia (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language
23/09/2025 11:30
Sept 23 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO ANNOUNCES FDA APPROVES IMPROVED ZENRELIA™ (ILUNOCITINIB TABLETS) LABEL, REMOVING VACCINE-INDUCED DISEASE LANGUAGE ELANCO ANIMAL HEALTH INC - FDA REMOVES FATAL VACCINE-INDUCED DISEASE RISK FROM LABELING ELANCO ANIMAL HEALTH INC - LABEL BOXED WARNING CONTINUES TO ADVISE DISCONTINUATION OF ZENRELIA FOR AT LEAST 28 DAYS TO 3 MONTHS PRIOR TO VACCINATION ELANCO ANIMAL HEALTH INC - LABEL BOXED WARNING CONTINUES TO ADVISE WITHHOLDING ZENRELIA FOR AT LEAST 28 DAYS AFTER VACCINATION Source text: ID:nPn9VhqhYa Further company coverage: ELAN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elanco Animal Health Incorporated
See all newsBrief: Elanco Animal Health Appoints Jamie Preston As Chief People Officer
U.S. STOCKS ON THE MOVE-Walt Disney, Alphabet, Kraft Heinz
U.S. STOCKS ON THE MOVE-Wynn Resorts, Griffon, Kratos Defense, Amgen
Elanco Animal Health Incorporated reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cencora, Charles River, Twist Bioscience